blazeispirol A | 221115-51-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 萘并吡喃类
• 英文名称: blazeispirol A
• 英文别名: (1R,3'R,4'S,10R,11R,12S,13S)-5-methoxy-4',5',5',6,10,12-hexamethylspiro[14-oxatetracyclo[9.3.2.01,10.02,7]hexadeca-2(7),3,5,8-tetraene-13,2'-oxolane]-3'-ol
• CAS: 221115-51-1
• 化学式: C₂₅H₃₄O₄
• 分子量: 398.543
• InChiKey: QJEDIZUTQZCCNK-TVHHQFAESA-N

物化性质

• 沸点：
  525.3±50.0 °C(Predicted)
• 密度：
  1.18±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  29
• 可旋转键数：
  1
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.68
• 拓扑面积：
  47.9
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  blazeispirol A 在 三氟化硼乙醚 作用下， 以 氯仿 为溶剂， 反应 0.5h， 生成 (20S,22R,24R)-22,25-epoxy-5-methoxy-14β-methyl-18-nor-des-A-ergosta-5,7,9,11,13(17)-pentaen-23-one 、 (23S,24S)-13,23-cyclo-25-hydroxy-14β-methyl-18-nor-des-A-ergosta-5,7,9,11,17(20)-pentaen-22-one 、 (17R,20S,24S)-17(13->7)abeo-20,25-epoxy-5-methoxy-des-A-ergosta-5,7,9,11,13-pentaen-22-one 、 (17S,20S,24S)-17(13->7)abeo-20,25-epoxy-5-methoxy-des-A-ergosta-5,7,9,11,13-pentaen-22-one
  参考文献：
  名称：

  Agariblazeispirol C from the cultured mycelia of the fungus, Agaricus blazei, and the chemical conversion of blazeispirol A

  摘要：

  Agariblazeispirol C, which has a unique steroidal skeleton, has been isolated from the cultured mycelia of Agaricus blazei (Agaricaceae). The structure of agariblazeispirol C was established to be (23S,24S)-13,23-cyclo-25-hydroxy-14beta-methyl-18-nor-des-Aergosta-5,7,9,11,17(20)-pentaen-22-one by comparison of extensive 1D and 2D NMR spectral data with those of agariblazeispirols A and B. At the same time, agariblazeispirol C was synthesized by the reaction of blazeispirol A with BF3.OEt2 along with some interesting compounds. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2004.10.051

文献信息

• Terpenoid spiro ketal compounds with LXR agonists activity, their use and formulations with them
  申请人：InterMed Discovery GmbH

  公开号：EP2468253A1

  公开（公告）日：2012-06-27

  The invention relates to the use, or methods (especially with regard to animals, especially human, that are in need of such treatment) comprising the use, respectively, of an extract and/or especially one or more natural spiro triterpenoids and derivatives thereof, especially from the blazeispirol family, obtainable from Agaricus species, alone or as supplement, as active ingredient in the prophylactic and/or therapeutic treatment of a disease, disorder or condition that responds to the modulation of Liver X receptor, either in humans or in other mammals, and/or to the use of said extract and/or natural compound(s) or mixtures for the treatment of said disease, disorder or condition, as well as corresponding methods of treatment, or their use in the manufacture of a pharmaceutical or nutraceutical formulation for said treatment. The invention relates also to said extract and/or compound(s) for use in the treatment or in the preparation of a medicament (including a nutraceutical) for the prophylactic and/or therapeutic treatment of said disorder, disorder or condition, as well as their preparation. It also relates to pharmaceutical or nutraceutical formulations comprising said extract and/or natural compound(s) which are useful in said prophylactic and/or therapeutic treatment. They can also be used for non-therapeutic, e.g. cosmetic, purposes only.

  本发明涉及姬松茸提取物和/或特别是一种或多种天然螺三萜类及其衍生物，尤其是从姬松茸中提取的blazeispirol家族中的一种或多种天然螺三萜类及其衍生物的使用或方法（尤其是针对需要此类治疗的动物，特别是人类），作为预防和/或治疗疾病的活性成分、本发明还涉及上述提取物和/或天然化合物或混合物用于治疗上述疾病、紊乱或病症的用途，以及相应的治疗方法，或它们在制造用于上述治疗的药物或保健品配方中的用途。本发明还涉及用于治疗或制备预防和/或治疗上述疾病、失调或病症的药物（包括营养保健品）的上述提取物和/或化合物，以及它们的制备方法。它还涉及包含上述提取物和/或天然化合物的药物或保健品制剂，这些制剂可用于上述预防和/或治疗。它们也可仅用于非治疗目的，如美容。
• US9453016B2
  申请人：——

  公开号：US9453016B2

  公开（公告）日：2016-09-27
• [EN] TERPENOID SPIRO KETAL COMPOUNDS WITH LXR AGONISTS ACTIVITY, THEIR USE AND FORMULATIONS WITH THEM<br/>[FR] COMPOSÉS DE SPIRO-CÉTAL TERPÉNOÏDE AVEC DES AGONISTES DE LXR, LEUR UTILISATION ET FORMULATIONS AVEC CEUX-CI
  申请人：INTERMED DISCOVERY GMBH

  公开号：WO2012079721A1

  公开（公告）日：2012-06-21

  The invention relates to the use, or methods (especially with regard to animals, especially human, that are in need of such treatment) comprising the use, respectively, of an extract and/or especially one or more natural spiro triterpenoids and derivatives thereof, especially from the blazeispirol family, obtainable from Agaricus species, alone or as supplement, as active ingredient in the prophylactic and/or therapeutic treatment of a disease, disorder or condition that responds to the modulation of Liver X receptor, either in humans or in other mammals, and/or to the use of said extract and/or natural compound(s) or mixtures for the treatment of said disease, disorder or condition, as well as corresponding methods of treatment, or their use in the manufacture of a pharmaceutical or nutraceutical formulation for said treatment. The invention relates also to said extract and/or compound(s) for use in the treatment or in the preparation of a medicament (including a nutraceutical) for the prophylactic and/or therapeutic treatment of said disorder, disorder or condition, as well as their preparation. It also relates to pharmaceutical or nutraceutical formulations comprising said extract and/or natural compound(s) which are useful in said prophylactic and/or therapeutic treatment. They can also be used for non-therapeutic, e.g. cosmetic, purposes only.